drugset / Trial / NCT01421940

The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer

NCT01421940

Phase 4 Completed 80 enrolled Kyungpook National University Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

Sexual dysfunctions are well-recognized complications after rectal cancer surgery. Damage to the pelvic plexus and pelvic splanchnic nerves results in ejaculatory dysfunction. The purpose of this study is to evaluate the efficacy of Udenafil(Zydena®, Dong-A Pharmaceutical co., Ltd, Seoul, Korea) in penile rehabilitation for patients who undertake total mesorectal excision.

Timeline

Start
2009-10
Primary completion
2011-12
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Udenafil Small molecule 50 mg Oral

Indications